| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: IMMY |
| Security Type |
Common Stock |
| Lead Underwriter |
MDB Capital Corp |
| Days In Registration |
197 |
| Date Filed |
25-Jul-2012 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Imprimis Pharmaceuticals Inc, based in Solana Beach, California, manufactures pharmaceuticals. Its products include Ketotransdel comprised of a transdermal formulation of ketoprofen. It develops invasive and topically delivered products. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
8.61M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
276.0K |
| File Amount |
$15.0M |
| File Price Range |
- - - |
| File Mid Price |
- |
Current Filing Information
(Amended 4-Feb-2013) |
|
US |
|
Shares Filed |
1.62M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
1.62M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$8.5M |
| · % Change from Original |
-43.33 |
| File Price Range |
$5.25 - $5.25 |
| File Mid Price |
$5.25 |
|
